Cragg, Amber
39  results:
Search for persons X
?
2

Validating methods used to identify non‐adherence adverse d..:

Wickham, Maeve E. ; McGrail, Kimberlyn M. ; Law, Michael R...
British Journal of Clinical Pharmacology.  90 (2024)  5 - p. 1240-1246 , 2024
 
?
3

Validating use of diagnostic codes in Canadian administrati..:

Wickham, Maeve E. ; McGrail, Kimberlyn M. ; Law, Michael R...
British Journal of Clinical Pharmacology.  90 (2024)  7 - p. 1688-1698 , 2024
 
?
9

XPO1 inhibition sensitises CLL cells to NK cell mediated cy..:

Fisher, Jack G ; Doyle, Amber D.P ; Graham, Lara V...
https://eprints.soton.ac.uk/480661/1/s41375_023_01984_z.pdf.  , 2023
 
?
10

Comparing methods to classify admitted patients with SARS-C..:

Corinne M. Hohl ; Amber Cragg ; Elizabeth Purssel...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522023/?tool=EBI.  , 2023
 
?
11

Comparing methods to classify admitted patients with SARS-C..:

Corinne M Hohl ; Amber Cragg ; Elizabeth Purssel...
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0291580&type=printable.  , 2023
 
?
12

Sharing Adverse Drug Event Reports Between Hospitals and Co..:

Cragg, Amber ; Small, Serena S ; Lau, Erica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632212/.  , 2023
 
?
 
1-15